The cost of generic Trelegy Ellipta is not yet established, as the drug is still under patent protection. Trelegy Ellipta is a combination inhaler containing fluticasone furoate, umeclidinium, and vilanterol, used to treat patients with COPD [1].
When Will Generic Trelegy Be Available?
The patent exclusivity for Trelegy Ellipta is anticipated to expire in the coming years. According to DrugPatentWatch.com, key patents for Trelegy Ellipta are set to expire around 2029 [2]. This timeline suggests that generic versions of the medication could become available after this period, potentially leading to lower costs.
How Much Does Trelegy Ellipta Cost Now?
Currently, as Trelegy Ellipta is a branded medication with patent protection, its cost can be significant. Prices vary based on insurance coverage, pharmacy, and whether a patient is using a discount program. For example, a 30-day supply without insurance might cost several hundred dollars [1].
What Factors Influence Generic Drug Pricing?
Once a drug loses patent protection, multiple manufacturers can produce generic versions. Increased competition among these manufacturers typically drives down the price of the medication. The availability and cost of generic Trelegy will depend on the number of companies that decide to produce it and the manufacturing complexities involved.
Can Patients Access Trelegy at a Lower Cost Before Generics?
Patients may be able to reduce their out-of-pocket expenses for Trelegy Ellipta through various patient assistance programs offered by the manufacturer or through their insurance provider's formulary, which may offer lower co-pays for preferred medications. Discount cards and coupons can also offer temporary savings [1].
What are the Alternatives to Trelegy Ellipta?
For COPD treatment, other inhaler options exist, including single-ingredient bronchodilators, combination inhalers with different active agents, and other inhaled corticosteroid combinations. The choice of alternative depends on the individual patient's needs, symptom severity, and physician's recommendation [1].
Sources:
1. Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) inhalant: Uses, side effects, dosage, price & interactions - Drugs.com. https://www.drugs.com/trelegy.html
2. Trelegy Ellipta Patent Expiration - DrugPatentWatch.com. https://drugpatentwatch.com/drug/trelegy-ellipta/patent